China National Accord Medicines Corporation Ltd. (SHE:000028)
China
· Delayed Price · Currency is CNY 24.80
+0.11 (0.45%)
Apr 29, 2026, 3:04 PM CST
SHE:000028 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 12,841 | 12,773 | 15,153 | 14,937 | 13,164 | 14,706 | Upgrade
|
| Market Cap Growth | -2.85% | -15.71% | 1.44% | 13.47% | -10.48% | -18.89% | Upgrade
|
| Enterprise Value | 12,560 | 15,631 | 20,171 | 20,008 | 15,577 | 18,367 | Upgrade
|
| Last Close Price | 24.69 | 24.56 | 28.82 | 27.97 | 24.08 | 26.53 | Upgrade
|
| PE Ratio | 12.53 | 11.24 | 23.59 | 9.34 | 8.85 | 11.00 | Upgrade
|
| Forward PE | 11.54 | 10.36 | 16.43 | 10.10 | 10.14 | 10.13 | Upgrade
|
| PS Ratio | 0.18 | 0.17 | 0.20 | 0.20 | 0.18 | 0.22 | Upgrade
|
| PB Ratio | 0.59 | 0.59 | 0.73 | 0.71 | 0.68 | 0.82 | Upgrade
|
| P/TBV Ratio | 0.77 | 0.77 | 0.99 | 1.06 | 1.03 | 1.28 | Upgrade
|
| P/FCF Ratio | - | 8.99 | 5.07 | 5.71 | 5.88 | 11.45 | Upgrade
|
| P/OCF Ratio | - | 7.80 | 4.63 | 5.09 | 5.14 | 8.89 | Upgrade
|
| PEG Ratio | - | 0.27 | 3.29 | 0.70 | 1.77 | 1.77 | Upgrade
|
| EV/Sales Ratio | 0.17 | 0.21 | 0.27 | 0.27 | 0.21 | 0.27 | Upgrade
|
| EV/EBITDA Ratio | 4.92 | 8.09 | 6.50 | 5.22 | 6.13 | 8.21 | Upgrade
|
| EV/EBIT Ratio | 7.58 | 9.09 | 12.96 | 8.30 | 6.78 | 9.04 | Upgrade
|
| EV/FCF Ratio | - | 11.00 | 6.75 | 7.65 | 6.96 | 14.30 | Upgrade
|
| Debt / Equity Ratio | 0.21 | 0.21 | 0.28 | 0.26 | 0.23 | 0.27 | Upgrade
|
| Debt / EBITDA Ratio | 1.77 | 1.53 | 1.85 | 1.40 | 1.22 | 1.46 | Upgrade
|
| Debt / FCF Ratio | - | 3.17 | 1.92 | 2.06 | 1.96 | 3.73 | Upgrade
|
| Net Debt / Equity Ratio | -0.15 | -0.15 | -0.08 | -0.05 | -0.08 | -0.02 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.14 | -1.70 | -0.54 | -0.29 | -0.64 | -0.15 | Upgrade
|
| Net Debt / FCF Ratio | - | -2.32 | -0.56 | -0.43 | -0.73 | -0.26 | Upgrade
|
| Asset Turnover | - | 1.52 | 1.56 | 1.67 | 1.72 | 1.66 | Upgrade
|
| Inventory Turnover | - | 8.45 | 8.60 | 8.40 | 8.35 | 8.68 | Upgrade
|
| Quick Ratio | - | 1.18 | 1.16 | 1.11 | 1.06 | 1.02 | Upgrade
|
| Current Ratio | - | 1.54 | 1.52 | 1.49 | 1.51 | 1.42 | Upgrade
|
| Return on Equity (ROE) | - | 5.33% | 1.14% | 9.69% | 9.46% | 8.75% | Upgrade
|
| Return on Assets (ROA) | - | 2.23% | 2.04% | 3.34% | 3.36% | 3.08% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.80% | 6.88% | 3.29% | 10.14% | 9.92% | 9.65% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 7.50% | 6.80% | 10.40% | 10.60% | 10.00% | Upgrade
|
| Earnings Yield | 8.53% | 8.89% | 4.24% | 10.71% | 11.29% | 9.09% | Upgrade
|
| FCF Yield | - | 11.13% | 19.72% | 17.51% | 17.00% | 8.74% | Upgrade
|
| Dividend Yield | 2.49% | 2.51% | 1.27% | 2.43% | 2.56% | 1.74% | Upgrade
|
| Payout Ratio | - | 34.01% | 93.97% | 34.96% | 38.62% | 45.68% | Upgrade
|
| Buyback Yield / Dilution | 0.16% | 0.38% | -0.26% | -0.12% | 0.00% | - | Upgrade
|
| Total Shareholder Return | 2.67% | 2.89% | 1.01% | 2.31% | 2.56% | 1.74% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.